Ziege anti-Human IgA Antikörper (Cy3)
Kurzübersicht für Ziege anti-Human IgA Antikörper (Cy3) (ABIN2176426)
Target
Klonalität
Konjugat
Applikation
Isotyp
-
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Aufreinigung
- Purified by Protein A.
-
-
-
-
Applikationshinweise
-
IF(IHC-P): (1:500-2000), IF(IHC-F): (1:500-2000), IF(ICC): (1:500-1000)
Optimal working dilution should be determined by the investigator. -
Kommentare
-
Exitation/Emission: 512,550nm/570,615nm
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at 4 °C for 12 months.
-
-
- IgA
-
Substanzklasse
- Antibody
-
Hintergrund
- Immunoglobulin A (IgA) is an antibody that plays a critical role in mucosal immunity. More IgA is produced in mucosal linings than all other types of antibody combined,[1] between three and five grams are secreted into the intestinal lumen each day.[2] This accumulates to 75 % of the total immunoglobulin produced in the entire body.
Target
-